Expression Therapeutics is a biotechnology company providing products for hemophilia care. It develops gene therapies for hemophilia A and B, neuroblastoma, T-cell leukemia/lymphoma, acute myeloid leukemia, and hematologic disorders such as hemophagocytic lymphohistiocytosis.